PPD recently conducted a multicenter, post-marketing study of a biologic injectable to evaluate transfer of the drug into breast milk in lactating mothers receiving treatment for Crohn’s or rheumatologic diseases. Read this case study to learn how an innovative operational model was deployed to overcome enrollment challenges in order to allow patients to participate who may not have been interested in, or capable of, participating in a traditionally designed clinical study.
Click on the image below to view the case study as a .pdf file. For faster viewing, right click and save the file to your computer.
Learn more about PPD Innovation.